Patent · US Active

Heterocyclic CETP inhibitors

US8304403B2 · kind B2 · utility

1Cited by

5References

17Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Mark E. Salvati · Lawrenceville, US
Heather Finlay · Skillman, US
Bang-Chi Chen · Cranbury, US
Lalgudi S. Harikrishnan · Princeton, US
Ji Jiang · Plainsboro, US
James A. Johnson · Lawrenceville, US
Muthoni G. Kamau · Lawrenceville, US
R. Michael Lawrence · Yardley, US
Jianqing Li · Guilford, US
John Lloyd · Yardley, US
Michael M. Miller · Lambertville, US
Zulan Pi · Pennington, US
Jennifer X. Qiao · Princeton, US
Richard A. Rampulla · Whitehouse Station, US
Jacques Y. Roberge · Princeton, US
Tammy C. Wang · Lawrenceville, US
Yufeng Wang · Mountain View, US
Wu-Der Yang · Taoyuan, TW

Key dates

Filing date	Jun 10, 2010
Grant date	Nov 6, 2012
Priority date	—
Expiry date	Jul 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of formula Ia and Ibandwherein A, B, C and R1 are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.